期刊文献+

Engel模式疏肝方法对肝郁型卵巢早衰干预的临床研究 被引量:1

Clinical Study of the POF of Liver Stagnation Syndrome under the Engel Model Liver Soothing Intervention
暂未订购
导出
摘要 [目的]研究Engel模式疏肝方法对卵巢早衰干预的效果。[方法]将51例具有卵巢早衰趋势并符合肝郁证型的患者分为Engel组、辅助组、中药组3组,辅助组予以解郁三花汤、敲胆经、健康教育;中药组予逍遥散主方;Engel组结合上述两组方法,治疗过程观察潮热汗出、阴道干涩、皮肤蚁行感等临床症状改善情况、血清生殖激素变化情况和不良反应等,并进行组间比较。[结果]与辅助组、中药组进行比较,Engel组对肝郁证型有干预作用,能明显缓解临床症候和改善卵巢功能(P<0.05)。[结论]Engel模式疏肝方法在对肝郁型卵巢功能减退有很好的治疗作用,对干预卵巢早衰有很好的辅助意义。 [Objective]To study the intervention effect of the Engel Model ’s liver soothing method to POF. [Methods] Divide 51 patients who have a POF trend and confirm to liver stagnation syndrome into Engel group, Assistant group and the Chinese medicine group. Intervene the 3 groups and compare the serum index and clinical manifestations before and after treatment. Assistant group used Sanhua decoction, Gal badder meridian tapping and health education. The Chinese medicine group applied the Xiaoyao powder. Engel group used both the methods of other two groups. During the intervention, we observed the change of tidal fever, perspiration, colpoxerosis and so on. [Results] Compare with the other groups, Engel group received an obvious intervention effect toward liver stagnation syndrome of POF trend. It could remit the clinical symptoms and improve ovarian function. [Conclusions] The Engel Model’s liver soothing method has a preventive and therapeutic effect on ovarian function recession of liver stagnation syndrome and has assistant meaning to treat the POF.
机构地区 浙江中医药大学
出处 《浙江中医药大学学报》 CAS 2014年第3期274-276,282,共4页 Journal of Zhejiang Chinese Medical University
基金 浙江中医药管理局项目(2008WA001)~~
关键词 Engel模式 卵巢早衰 肝郁 疏肝 Engel model POF liver stagnation liver soothing
  • 相关文献

参考文献6

二级参考文献20

  • 1卢莉,李建平,薛云珍,赵红卫,梁执群.情绪反应、个性特征与月经失调的关系[J].中国心理卫生杂志,2005,19(3):156-158. 被引量:47
  • 2谭贝加,马红.卵巢早衰研究进展[J].天津中医药,2007,24(3):260-261. 被引量:22
  • 3乐杰.妇产科学(第5版)[M].北京:人民卫生出版社,2003.371.
  • 4庞震苗,梁菁,邓高丕.卵巢早衰患者个性特征及心理健康状况调查[J].临床心身疾病杂志,2007,13(5):428-430. 被引量:17
  • 5Laml T, Schulz- Lobmeyr I, Obruca A, et al. Premature ovarian failure:etiology and prospects. Gynecol Endocrinol,2000 Aug, 14:292-302.
  • 6Kim TJ, Anasti JN, Flack MR, et al. Routine endocrine acreening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol, 1997,89:777-779.
  • 7Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinology and Metabolism Clinics of North America, 1998,27:989-1006.
  • 8Nelson LM, Anasti .IN, Kimaey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab, 1994,79:1470-1475.
  • 9Anasti JN, Kalantaridou SN, Kimzey LM, et al. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol, 1998,91 : 12-15.
  • 10Novosad JA, Kalantaridou SN, Tong ZB, et al. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health,2003,3: 2.

共引文献347

同被引文献13

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部